These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 23022917)

  • 21. Predictive timing functions of cortical beta oscillations are impaired in Parkinson's disease and influenced by L-DOPA and deep brain stimulation of the subthalamic nucleus.
    Gulberti A; Moll CK; Hamel W; Buhmann C; Koeppen JA; Boelmans K; Zittel S; Gerloff C; Westphal M; Schneider TR; Engel AK
    Neuroimage Clin; 2015; 9():436-49. PubMed ID: 26594626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-motor outcomes depend on location of neurostimulation in Parkinson's disease.
    Petry-Schmelzer JN; Krause M; Dembek TA; Horn A; Evans J; Ashkan K; Rizos A; Silverdale M; Schumacher W; Sack C; Loehrer PA; Fink GR; Fonoff ET; Martinez-Martin P; Antonini A; Barbe MT; Visser-Vandewalle V; Ray-Chaudhuri K; Timmermann L; Dafsari HS;
    Brain; 2019 Nov; 142(11):3592-3604. PubMed ID: 31553039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sevoflurane and Parkinson's Disease: Subthalamic Nucleus Neuronal Activity and Clinical Outcome of Deep Brain Stimulation.
    Tsai ST; Tseng GF; Kuo CC; Chen TY; Chen SY
    Anesthesiology; 2020 May; 132(5):1034-1044. PubMed ID: 32044799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subthalamic stimulation modulates cortical motor network activity and synchronization in Parkinson's disease.
    Weiss D; Klotz R; Govindan RB; Scholten M; Naros G; Ramos-Murguialday A; Bunjes F; Meisner C; Plewnia C; Krüger R; Gharabaghi A
    Brain; 2015 Mar; 138(Pt 3):679-93. PubMed ID: 25558877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease.
    Arai E; Arai M; Uchiyama T; Higuchi Y; Aoyagi K; Yamanaka Y; Yamamoto T; Nagano O; Shiina A; Maruoka D; Matsumura T; Nakagawa T; Katsuno T; Imazeki F; Saeki N; Kuwabara S; Yokosuka O
    Brain; 2012 May; 135(Pt 5):1478-85. PubMed ID: 22522940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The modulatory effect of adaptive deep brain stimulation on beta bursts in Parkinson's disease.
    Tinkhauser G; Pogosyan A; Little S; Beudel M; Herz DM; Tan H; Brown P
    Brain; 2017 Apr; 140(4):1053-1067. PubMed ID: 28334851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurofeedback-enabled beta power control with a fully implanted DBS system in patients with Parkinson's disease.
    Rohr-Fukuma M; Stieglitz LH; Bujan B; Jedrysiak P; Oertel MF; Salzmann L; Baumann CR; Imbach LL; Gassert R; Bichsel O
    Clin Neurophysiol; 2024 Sep; 165():1-15. PubMed ID: 38941959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-Time Neurofeedback to Modulate β-Band Power in the Subthalamic Nucleus in Parkinson's Disease Patients.
    Fukuma R; Yanagisawa T; Tanaka M; Yoshida F; Hosomi K; Oshino S; Tani N; Kishima H
    eNeuro; 2018; 5(6):. PubMed ID: 30627648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial.
    Witt K; Granert O; Daniels C; Volkmann J; Falk D; van Eimeren T; Deuschl G
    Brain; 2013 Jul; 136(Pt 7):2109-19. PubMed ID: 23801735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of delayed feedback deep brain stimulation for intermittent pathological synchronization in Parkinson's disease.
    Dovzhenok A; Park C; Worth RM; Rubchinsky LL
    PLoS One; 2013; 8(3):e58264. PubMed ID: 23469272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The FM/AM world is shaping the future of deep brain stimulation.
    Fasano A; Lozano AM
    Mov Disord; 2014 Feb; 29(2):161-3. PubMed ID: 24591170
    [No Abstract]   [Full Text] [Related]  

  • 32. Impact of subthalamic stimulation and medication on proximal and distal bradykinesia in Parkinson's disease.
    Potter-Nerger M; Wenzelburger R; Deuschl G; Volkmann J
    Eur Neurol; 2009; 62(2):114-9. PubMed ID: 19521088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional and effective connectivity in subthalamic local field potential recordings of patients with Parkinson's disease.
    Hohlefeld FU; Huchzermeyer C; Huebl J; Schneider GH; Nolte G; Brücke C; Schönecker T; Kühn AA; Curio G; Nikulin VV
    Neuroscience; 2013 Oct; 250():320-32. PubMed ID: 23876322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of low-frequency stimulation of the subthalamic nucleus on movement in Parkinson's disease.
    Eusebio A; Chen CC; Lu CS; Lee ST; Tsai CH; Limousin P; Hariz M; Brown P
    Exp Neurol; 2008 Jan; 209(1):125-30. PubMed ID: 17950279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuromuscular correlates of subthalamic stimulation and upper limb freezing in Parkinson's disease.
    Scholten M; Klotz R; Plewnia C; Wächter T; Mielke C; Bloem BR; Braun C; Ziemann U; Govindan RB; Gharabaghi A; Krüger R; Weiss D
    Clin Neurophysiol; 2016 Jan; 127(1):610-620. PubMed ID: 25792072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain networks modulated by subthalamic nucleus deep brain stimulation.
    Accolla EA; Herrojo Ruiz M; Horn A; Schneider GH; Schmitz-Hübsch T; Draganski B; Kühn AA
    Brain; 2016 Sep; 139(Pt 9):2503-15. PubMed ID: 27412387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversing cognitive-motor impairments in Parkinson's disease patients using a computational modelling approach to deep brain stimulation programming.
    Frankemolle AM; Wu J; Noecker AM; Voelcker-Rehage C; Ho JC; Vitek JL; McIntyre CC; Alberts JL
    Brain; 2010 Mar; 133(Pt 3):746-61. PubMed ID: 20061324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-frequency coupling between gamma oscillations and deep brain stimulation frequency in Parkinson's disease.
    Muthuraman M; Bange M; Koirala N; Ciolac D; Pintea B; Glaser M; Tinkhauser G; Brown P; Deuschl G; Groppa S
    Brain; 2020 Dec; 143(11):3393-3407. PubMed ID: 33150359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilateral effects of unilateral subthalamic deep brain stimulation on Parkinson's disease at 1 year.
    Walker HC; Watts RL; Guthrie S; Wang D; Guthrie BL
    Neurosurgery; 2009 Aug; 65(2):302-9; discussion 309-10. PubMed ID: 19625909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease.
    Dafsari HS; Silverdale M; Strack M; Rizos A; Ashkan K; Mahlstedt P; Sachse L; Steffen J; Dembek TA; Visser-Vandewalle V; Evans J; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L;
    Mov Disord; 2018 Mar; 33(3):421-430. PubMed ID: 29465787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.